What is the role of early intervention in SSD prognosis?

• A. No impact on outcome.
• B. Associated with better prognosis.
• C. Worsens prognosis.
• D. Only affects response to medication.

Answer: (B)

Early intervention helps prognosis because it interrupts the cycle that keeps somatic symptom disorder persistent. When care is timely and collaborative, patients receive validation of distress while also learning how thoughts, emotions, and behaviors amplify symptoms. This reduces catastrophizing and symptom-focused attention, which in turn lowers avoidance and overmedicalization.

A proactive, biopsychosocial approach—often including psychoeducation, a steady medical follow-up, and therapies like cognitive-behavioral techniques plus graded activity—improves coping, function, sleep, mood, and overall quality of life. By addressing triggers early and helping patients regain engagement in daily activities, early intervention lowers the risk of chronicity, persistent disability, and comorbid anxiety or depression.

Other choices don’t fit because evidence supports better outcomes with timely management, not no impact or worsening prognosis. And prognosis in SSD is driven more by early, effective psychosocial and medical management rather than medication response alone, so saying it only affects response to medication isn’t accurate.